Salt CompositionYou Searched
Mertabto 50mg Tablet
Emcure Pharmaceuticals Ltd.
₹44
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Used In
Blood cancer
Customers also bought
More About Mertabto
Benefits
In Blood cancer : Blood cancer, also called leukemia, is a cancer of the blood-forming tissues, that decreases the body's ability to fight infection. Mertabto 50mg Tablet kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is an effective medicine but you should discuss the side effects and benefits of this medicine with your doctor. Let your doctor know if any of the side effects bothers you.
Side Effects
Side effects of Mertabto Tablet The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you�re worried about them Common side effects of Mertabto Nausea Vomiting Rash Decreased white blood cell count (neutrophils)Intestinal ulcer Anemia (low number of red blood cells)Increased bilirubin in the blood Low blood platelets Increased transaminase level in blood Diarrhea Loss of appetite
How to use
How to use Mertabto Tablet Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Mertabto 50mg Tablet can be taken it with or without food, although it's advisable to take it consistently at the same time.
How it works
How Mertabto Tablet works Mertabto 50mg Tablet interferes with the growth of DNA and RNA of the cancer cells by substituting their building blocks. It prevents the cancer cells from growing and multiplying.
Consult your Doctor: Please consult your doctor regarding the safety of consuming alcohol with Mertabto 50mg Tablet . Experts have not found evidence of alcohol impairing the effectiveness of the medicine.
Mertabto 50mg Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Doctor consultation is advised.
Mertabto 50mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Mertabto 50mg Tablet does not usually affect your ability to drive.
Mertabto 50mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Mertabto 50mg Tablet may be needed. Doctor consultation is advised.
Mertabto 50mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Mertabto 50mg Tablet may be needed. Doctor consultation is advised.Inform your doctor if you develop any signs and symptoms of jaundice while taking this medicine.
Manufacturer Address
255/2, Hinjawadi, Pune - 411057, India
References
Chu E, Sartorelli AC. Cancer Chemotherapy. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 948
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 864-66
Mercaptopurine. Dublin, Ireland: Aspen; 2012 (29 Jan. 2019)
Drugs.com. Mercaptopurine Pregnancy and Breastfeeding Warnings (26 Mar. 2019)
Drugs and Lactation Database (LactMed) (18 Feb. 2020)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
